Pharming Group N.V. (PHAR) Operating margin 2019–2025
Pharming Group N.V. (PHAR) operating margin by fiscal year — reported operating income divided by reported revenue.
6.9%FY2025 · since FY2019: 36.0% → 6.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 6.9% | +9.8 pp |
| FY2024 | -2.9% | -0.7 pp |
| FY2023 | -2.2% | -11.1 pp |
| FY2022 | 8.9% | +2.0 pp |
| FY2021 | 6.8% | -29.1 pp |
| FY2020 | 35.9% | -0.1 pp |
| FY2019 | 36.0% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More PHAR financial trends
PHAR RevenuePHAR Net incomePHAR Net marginPHAR Gross profitPHAR Gross marginPHAR Operating incomePHAR Operating cash flowPHAR Free cash flowPHAR Capital expendituresPHAR Return on equityPHAR Stock buybacksPHAR Dividends paidPHAR Total assetsPHAR Total liabilitiesPHAR Shareholders’ equityPHAR overview →